Boenning & Scattergood’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $1.3M | Buy |
53,475
+23,215
| +77% | +$562K | 0.21% | 122 |
|
|
2022
Q3 | $495K | Sell |
30,260
-200
| -0.7% | -$3.27K | 0.1% | 224 |
|
|
2022
Q2 | $429K | Sell |
30,460
-23,015
| -43% | -$324K | 0.08% | 248 |
|
|
2022
Q1 | $1.3M | Hold |
53,475
| – | – | 0.21% | 122 |
|
|
2021
Q4 | $1.25M | Sell |
53,475
-400
| -0.7% | -$9.34K | 0.2% | 126 |
|
|
2021
Q3 | $894K | Sell |
53,875
-5,000
| -8% | -$83K | 0.16% | 155 |
|
|
2021
Q2 | $1.44M | Buy |
58,875
+25,000
| +74% | +$610K | 0.25% | 108 |
|
|
2021
Q1 | $874K | Hold |
33,875
| – | – | 0.17% | 149 |
|
|
2020
Q4 | $1.81M | Hold |
33,875
| – | – | 0.38% | 68 |
|
|
2020
Q3 | $1.4M | Buy |
33,875
+400
| +1% | +$16.5K | 0.34% | 78 |
|
|
2020
Q2 | $1.62M | Hold |
33,475
| – | – | 0.43% | 57 |
|
|
2020
Q1 | $1.41M | Buy |
33,475
+3,875
| +13% | +$164K | 0.49% | 52 |
|
|
2019
Q4 | $1.27M | Buy |
29,600
+3,000
| +11% | +$128K | 0.33% | 76 |
|
|
2019
Q3 | $957K | Hold |
26,600
| – | – | 0.28% | 104 |
|
|
2019
Q2 | $711K | Sell |
26,600
-25,050
| -48% | -$670K | 0.21% | 127 |
|
|
2019
Q1 | $1.39M | Buy |
51,650
+2,350
| +5% | +$63.1K | 0.42% | 68 |
|
|
2018
Q4 | $797K | Buy |
49,300
+3,000
| +6% | +$48.5K | 0.28% | 104 |
|
|
2018
Q3 | $961K | Sell |
46,300
-400
| -0.9% | -$8.3K | 0.31% | 92 |
|
|
2018
Q2 | $713K | Buy |
+46,700
| New | +$713K | 0.23% | 125 |
|